Introduction
Culture of blood is a fundamental investigation in infection. Illness associated with bacteraemia ranges from self limiting infection to life threatening sepsis that requires rapid and aggressive antimicrobial treatment, 1 which is complicated by increasing antibiotic resistance worldwide. [2] [3] [4] [5] Information on trends and antibiotic resistance in bacteraemia is needed to inform prescribing and infection control policy and to guide development of new antibiotics and vaccines. 1 3-7 Since 1989 blood isolates judged to be clinically significant by microbiologists working in laboratories in England and Wales have been reported to the Public Health Laboratory Service Communicable Disease Surveillance Centre; this moved from paper to electronic transmission with EpiBase 8 then CoSurv. 9 Trends in resistance to key antibiotics have been published for Staphylococcus aureus, 10 11 Streptococcus pneumoniae, 12 and Escherichia coli. 13 Here we present the first overall description of the system and causative organisms with further information on antibiotic resistance.
Methods
Blood isolates reported to the surveillance centre from 1990 to 1998 were entered on a computer database (LabBase). 8 Replicate reports were identified by matching on date of birth, sex, specimen date, organism, antibiotic susceptibility, and source laboratory and merged if the specimen dates were less than eight days apart. This was undertaken manually from 1990 to 1994 and then by computer program.
We identified laboratories in England and Wales that reported blood isolates to the surveillance centre in 1998 from the Directory of the Association of Medical Microbiologists.
14 Annual total bacteraemias and annual counts for each of 34 "categories" of bacteraemia defined by causative organism 15 were analysed by Poisson regression analysis. 16 Categories showing a year on year proportional increase were further analysed within age groups. The causes of bacteraemia between age groups were examined. Trends in the proportion resistant were determined for the subset of reports with a completed antibiotic susceptibility field. Intermediate resistance was recorded in less than 0.7% of reports and was counted as resistance. Staph aureus was among the top five causes of bacteraemia in every age group, whereas E coli, coagulase negative staphylococci, Strep pneumoniae, and Enterococcus species ranked lower at certain ages ( fig 2) . and non-haemolytic streptococci (excluding pneumococci) accounted for 5-7% of bacteraemias in children of all ages and for 2-4% aged over 14 years. Group B streptococci comprised 22% of reports in infants aged 0 to 28 days, 5% in infants aged 29 days to 1 year, were rare in children aged between 1 and 14 years (three reports in 1998), but contributed 1-2% in the adult age groups. Neisseria meningitidis accounted for 11-17% of reports in age groups from birth to 14 years, 2% from 15 to 44 years, and less than 1% in older age groups. The proportion of reports contributed by each age group to each category of bacteraemia was similar in every year.
Results

Of 229 laboratories identified in England and
The subset of reports with completion of the antibiotic susceptibility field generally declined in 1996 and 1997 and recovered in 1998 (fig 3) . Methicillin resistance in Staph aureus increased from 1.7% to 3.8% from 1990 to 1993, rose steeply to 32% in 1997 and to 34% in 1998 ( fig 3) . Gentamicin resistance in E coli 
Discussion
The number of reports increased yearly; a steep increase between 1996 and 1998 ( fig 1) coincided with efforts to encourage reporting, including "free" installation of CoSurv 9 into laboratories, but the number bearing data on antimicrobial susceptibility did not increase except for methicillin against Staph aureus (fig 3) . This was probably due to problems in the introduction of CoSurv and different degrees of effort in chasing up missing results for each antimicrobial susceptibility. Increased reporting may also have reflected rising incidence due to improved survival of severely ill patients. 17 18 The causes of bacteraemia were similar to those seen in other large series. [17] [18] [19] Categories with a marked upward trend (table 1) are a priority for further research. The trend for Corynebacterium species and diphtheroids may reflect a change from regarding these organisms as skin contaminants to being clinically significant, as occurred for coagulase negative staphylococci. 20 Marked increases in Acinetobacter species, Serratia species, Citrobacter species, and Enterobacter species may reflect their facility to develop mutational resistance to cephalosporin antibiotics, which were used increasingly during the survey period. We found no shift to Gram positive organisms as reported elsewhere. 1 17-20 This may have occurred before the study period or be specific to certain patient groups, such as patients with neutropaenia. The fall in H influenzae followed introduction of Hib immunisation in 1992. 21 The rise in antibiotic resistance in blood isolates emphasises the importance of sound hospital infection 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 Year Gentamicin: Escherichia coli 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 Year Vancomycin: Enterococcus faecium 1 9 9 0 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 No of reports 
What is already known on this subject
Bacteraemia series from laboratories and programmes of nosocomial infection surveillance are generally derived from individual or small numbers of institutions
The collated data may be unrepresentative of the general population and inferences may lack precision because of the small number of reports
The need for representative and precise information on the causes and trends in antibiotic resistance in blood stream infections at national level made an overview of the system desirable at this time
What this paper adds
Over 90% of laboratories in England and Wales reported clinically significant blood isolates to the communicable disease surveillance centre in 1998, with total reports ranging from about 30 000 in 1990 to 50 000 in 1998
This reporting system probably captures information on a sizeable proportion of episodes of bacteraemia at national level
The value of this system for national level monitoring of antibiotic resistance and trends in the causes of bacteraemia has been demonstrated; regional analyses with multivariable methods may prove useful in the future control, 6 7 rational prescribing policies, and the need for new antimicrobial drugs and vaccines. [3] [4] [5] Validation of reported data on resistance has been undertaken by comparison with centralised testing of nationally representative sample strains. 13 Regional analyses have been developed for methicillin against Staph aureus 22 (http://www.phls.co.uk/facts/bact.htm). Further analysis of these data could include the determination of the independent effect on antibiotic resistance of region, year, age, and sex by using multivariable methods. 16 This national reporting system should complement local surveillance of bacteraemia in which extensive data on risk factors may be collected. 23 24 We thank the microbiology laboratory staff in England and Wales for reporting isolates to the surveillance centre.
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A memorable patient Disability is in the mind of the beholder I met Dave in 1992, when we were both inpatients at a spinal injuries unit. Dave, a man in his early 30s, had suffered a complete high cervical spinal cord injury after diving into a swimming pool on holiday. His upper limb movement was extremely limited, which meant that he would need the use of an electrically powered wheelchair for mobility and help from others for most other things. I had sustained a complete midthoracic spinal cord injury in a tobogganing accident, resulting in permanent paraplegia. We had both been in hospital for a couple of months and we were at the stage of being put in wheelchairs. We were sitting in the ward and passing the time of day. I was finding the unsteady and vulnerable experience of wheelchair use quite frightening and unfamiliar. I asked Dave how he was getting on. Dave, who was very articulate, said something that really struck me, especially since my thoughts had been sensitised as to how important independence was. He said that he had been okay with all that had happened to him since his accident, until the other day. It was then that he had been put in a wheelchair for the first time. This chair was not motorised, and so a nurse pushed him to where he wanted to go. He had been left alone for a few minutes and it was at that moment that he felt completely stranded and utterly hopeless. He could not move anywhere unless he screamed for help. This made me look at myself and think how independent I was, rather than how dependent I was. I could not walk or do many of the things that I previously did, but I had not felt such extremes of isolation and total dependence. At the same time, I thought that there were people with more severe impairments than Dave. Dave was still cerebrally intact and able to attempt to rationalise his situation.
Time has passed. Dave now has the equipment that he needs and a full time carer. He is working again in a worthwhile job. I would never judge the extent of Dave's disablement: only he can quantify that. His few words did, however, drive home that living with a long term impairment is dynamic and idiosyncratic.
Tom Wells medical senior house officer, Bristol
We welcome articles of up to 600 words on topics such as A memorable patient, A paper that changed my practice, My most unfortunate mistake, or any other piece conveying instruction, pathos, or humour. If possible the article should be supplied on a disk. Permission is needed from the patient or a relative if an identifiable patient is referred to. We also welcome contributions for "Endpieces," consisting of quotations of up to 80 words (but most are considerably shorter) from any source, ancient or modern, which have appealed to the reader.
